Jiangsong Li
Papers
1
Total Citations
15
H-Index
1
About
Dr. Jiangsong Li has made significant contributions to urologic oncology, with a primary focus on optimizing surgical outcomes for bladder cancer patients. His most cited work, a 2019 systematic review and meta-analysis comparing minimally invasive radical cystectomy (MIRC) to open radical cystectomy (ORC), has garnered 15 citations and provides critical evidence on the efficacy and safety of these approaches. By systematically analyzing data from randomized controlled trials, Dr. Li’s research helps clarify the trade-offs between surgical techniques, guiding clinical decision-making in a field where treatment paradigms are rapidly evolving. His work underscores a commitment to evidence-based surgery, addressing key questions about recovery, complications, and oncologic control. Beyond this landmark study, Dr. Li’s broader research portfolio advances the understanding of urologic cancers, with a particular emphasis on refining surgical methods to improve patient outcomes. His contributions are valuable for clinicians and researchers seeking to balance innovation with rigorous evaluation, making him a respected voice in the ongoing dialogue about best practices in bladder cancer management.
Research Focus
Key Achievements
Top Papers
- 1